science wire

« BACK

Institut national de la santé et de la recherche médicale (INSERM)


Results 1 - 27 of 27.


Health - Psychology - 12.03.2024
Physical and mental well-being of older adults: a positive impact of meditation and health education
Learning mindfulness meditation improves self-compassion, while health education promotes an increase in physical activity.

Health - Life Sciences - 05.12.2023
2023 Inserm Prizes: Innovative research at the service of patients
'Through its Prizes, Inserm celebrates this year five emblematic winners of our collective effort to conduct and support health research with efficacy and creativity,' emphasises Inserm CEO, Prof. Didier Samuel.

Health - Pharmacology - 04.08.2023
Omicron BA.1 virus infection in vaccinated patients remodels immune memory
Alberto Domingo Lopez-Munoz, Laboratory of Viral Diseases, NIAID/NIH Teams from the internal medicine department of the Henri-Mondor AP-HP hospital, the Institut Necker - Enfants Malades, the Mondor I

Health - 08.06.2023
When We Always Benefit From Focusing on Health: Inserm Unveils Its New Advertising Campaign
When We Always Benefit From Focusing on Health: Inserm Unveils Its New Advertising Campaign
One year after its large-scale poster campaign in France's railway stations and Paris subway, Inserm uses its slogan On gagne tous les jours à s'intéresser à la santé [We always benefit from focusing on health] in a 30-second TV commercial broadcast from June 7 to July 30.

Event - 25.05.2023
InScience 2023: The Festival That Does Your Health Good
InScience 2023: The Festival That Does Your Health Good

Health - Pharmacology - 23.02.2023
New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Sexually Transmitted Bacterial Infections and proven efficacy of the MVA-BN Vaccine Against Mpox
New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Sexually Transmitted Bacterial Infections and proven efficacy of the MVA-BN Vaccine Against Mpox
Emerging Infectious Diseases in partnership with Roche , was conducted by a research team from the Paris Public Hospitals Group AP-HP, Université Paris Cité, Inserm, and Sorbonne Université in collaboration with the associations AIDES and Coalition PLUS.

Health - Pharmacology - 20.02.2023
Obesity and Overweight: Almost One in Two French People Affected. Current Situation, Prevention and Therapeutic Solutions
Photo i yunmai / Unsplash Obesity is a global public health problem whose incidence continues to increase.

Health - Pharmacology - 14.12.2022
Trial on safety and immunogenicity of Ebola vaccines yields promising results
Trial on safety and immunogenicity of Ebola vaccines yields promising results
Ebola epidemics occur periodically in various sub-Saharan African countries.

Health - Life Sciences - 06.12.2022
2022 Inserm Prizes: Forming a Common Front for Our Health
2022 Inserm Prizes: Forming a Common Front for Our Health
"Awarding the Inserm Prizes is a key point in the Institute's life, enabling us to showcase the various talents of our staff and the great wealth of the research we conduct to form a common front for the health of our fellow citizens.

Health - Psychology - 18.07.2022
Inserm and CNRS to Lead Large-Scale Program on Psychiatry Research
Inserm and CNRS to Lead Large-Scale Program on Psychiatry Research

Health - 18.05.2022
InScience 2022: An Inserm Festival
InScience 2022: An Inserm Festival

Health - 12.04.2022
Signing of a new joint Declaration of Intent between the Quebec Health Research Fund and Inserm
Signing of a new joint Declaration of Intent between the Quebec Health Research Fund and Inserm

Life Sciences - Health - 10.02.2022
A Gene Therapy Studied in Steinert's Disease
A Gene Therapy Studied in Steinert’s Disease
Myotonic dystrophy type 1 (DM1) or Steinert's disease is a rare and debilitating genetic neuromuscular disease affecting multiple organs and with a fatal outcome.

Health - Politics - 10.02.2022
Inserm Signs Its First Contract of Objectives, Means and Performance with the French State

Health - Pharmacology - 27.01.2022
Persistence of severe hepatic fibrosis despite substantial weight loss with bariatric surgery
Persistence of severe hepatic fibrosis despite substantial weight loss with bariatric surgery
A research team from AP-HP, Inserm and Sorbonne University carried out work, within the IHU ICAN, on the effects of bariatric surgery on the severity of liver damage in patients with NASH (Non-Alcoho

Health - Life Sciences - 20.10.2017
Gender and Health: Down with Clichés !

Health - Life Sciences - 20.10.2017
Careful With Clichés Related to Gender and Health!

Health - Career - 12.10.2017
Maternal and neonatal health : preliminary results of the French National Perinatal Survey 2016
The French National Institute for Health and Medical Research (Inserm) and the Directorate of Research, Studies, Evaluation and Statistics (DREES) have published the preliminary results of the French National Perinatal Survey 2016.

Health - Social Sciences - 22.09.2017
Maternal mortality: deaths from hemorrhage reduced but inequalities remain
Between 2010 and 2012, 256 women died in France from causes linked to pregnancy, labor, or following childbirth, amounting to 85 such cases a year.

Social Sciences - 28.04.2017
The creation of a pluridisciplinary Institute for the study of migration
The current migratory crisis in Europe shows the necessity to have solid scientific data to help public authorities take important decisions, in the context of emergencies and varied political situations.

Health - 04.04.2017
Intellectual Disabilities, a collective expert review by Inserm
According to the World Health Organisation and other recognised authorities, intellectual disability (ID) refers to an intelligence deficit (significantly reduced ability to understand new or complex information and learning and applying new skills) as well as limitations in adaptive functioning .

Administration - 20.03.2017
Inserm celebrates 10 years of the ERC

Administration - Health - 03.03.2017
Inserm in the world Top 10 most innovative public bodies, up one place compared to last year
Inserm is ranked 9th in the Reuters/Clarivate 'Top 25 Global Innovators - Government,' which evaluates the innovative capacity of public bodies according to the impact of their scientific output and patents.

Career - 20.02.2017
French institutions back the March for Science
On April 22, Earth Day 2017, the citizens of the world are invited to participate in a massive 'March for Science.

History / Archeology - Health - 31.01.2017
Inserm inaugurates its History Committee
Inserm announces the creation of its History Committee, reporting directly to its Chairman and Chief Executive Officer, Professor Yves Lévy.

Health - Life Sciences - 26.10.2016
Creation of first accelerators of technological research at Inserm
Inserm is launching its first accelerator of technological research according to the objective that is part of the Institute's strategic plan 2016-2020.

Life Sciences - Health - 16.06.2016
Brain tumours: ultrasound makes blood vessels permeable to enhance treatment delivery
Teams from the Paris Public Hospitals (AP-HP), Pierre and Marie Curie University, Inserm and the CarThera company (which is hosted by the Brain and Spine Institute [ICM]), coordinated by Prof.